NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

PinPoint Science Inc.

Business Name:
PinPoint Science Inc.
Business Genre:
Business Description:

PinPoint Science Inc. is a small company that was founded by Nader Pourmand, “Professor of Biomolecular Engineering and director of the UCSC Genome Technology Center at the University of California Santa Cruz, Baskin School of Engineering” [2]

City:
Berkeley
State:
CA
Country:
USA
Data/Evidence of Effectiveness:
They show some data detecting H5N1, HPV, and Bluetongue virus with nanopipettes and nanosensor chips on their website, but show no data for SARS-CoV-2 [3]. It seems like they have not chosen the antibody or apatamer that they will use for detection [3].
Complimentary Products Needed to Perform Test:
Nasopharyngeal swab or other sample collection device [3]
Setting of Care:
For use in a small clinic or at home [3]
Current Status / Clinical Development Stage / Expected Milestones:
“They are still in the development stage, but they planto functionalize their sensors to antibodies or aptamers against SARS-CoV-2 in June. It is not clear how much progress they have made on this front. Their goal is to get EUA approval in September. [3] “
Funding & Ownership :
It appears that they are funded by a few small grants. [3]
Business Model:
It seems like they are very early stage
IP:
They say that they have a patent pending for this technology [3] , and they have several patents related to nanopipette technology [4,5]
History & Origins :
It seems like the company was founded in 2017 and has been collecting data and small grants since then [1]. Nader Pourmand is a “Professor of Biomolecular Engineering and director of the UCSC Genome Technology Center at the University of California Santa Cruz, Baskin School of Engineering” . “Pourmand and his team hold over twenty patents. Pourmand has been published in more than 80 scientific journals including the Oxford University Press, Cancer Research, PLoS ONE and the Proceedings of the National Academy of Sciences. ” [1]
Date EUA Issued:
In development, their goal is to goal EUA approval in September [3]
Sources:
[1] https://pinpointscience.com [2]https://pinpointscience.com/team [3] https://pinpointscience.com/covid-19-test [4] https://patents.google.com/patent/US9228971B2/en?inventor=Nader+Pourmand&oq=Nader+Pourmand [5] https://patents.google.com/patent/US9766204B2/en?inventor=Nader+Pourmand&oq=Nader+Pourmand [6] https://pinpointscience.com/team
Organization:
CEO: Lisa Diamond, Founder: Dr. Nader Pourmand [6]
No. Tests Per Day:
>2000 samples/day
Time to Result:
30 seconds [3]
Test Sample Type:
They claim that their device can detect samples from swabs, blood, saliva, and more, but it is not clear if this applies to SARS-CoV-2 [3]
Technology Overview:
PinPoint’s device consists of a handheld console that communicates wirelessly with a Smartphone. A cartridge in which a nasal swab is inserted must be plugged into the console. They claim that they can get a diagnosis within 30 seconds and that the device costs only $100. This technology uses a “multichannel nanosensor chip” that is made by Analog Devices. How it works is that they functionalize antibodies or aptamers to nanopipette or nanosensor tips and upon antigen binding the current measured by the sensor is decreased. This decrease in current is detected by a circuit in the console and this info is relayed to the smartphone. [3]
Testing Type:
detection of either SARS-CoV-2 proteins or RNA [3] It seems like they have not chosen the antibody or apatamer that they will use for detection [3].
Test Category:
Other
Test Name:
Pinpoint Covid-19 Screening Assay
Clinical Application & Need:
acute infection [3]

Send Message to listing owner

Leave A Reply